Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v2-FR
Language French French
Date Updated 2023-01-25 2023-01-04
Drug Identification Number 02303922 02303922
Brand name JANUVIA JANUVIA
Common or Proper name sitagliptin tablets (as sitagliptin phosphate monohydrate) sitagliptin tablets (as sitagliptin phosphate monohydrate)
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients SITAGLIPTIN SITAGLIPTIN
Strength(s) 100MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 30
ATC code A10BH A10BH
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2023-01-04 2023-01-04
Actual start date 2023-01-04 2023-01-04
Estimated end date 2023-01-27 2023-01-27
Actual end date 2023-01-25
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments 100 tab format is available 100 tab format is available
Health Canada comments